Literature DB >> 25790881

DAPT duration after DES: what is the "mandatory" duration?

Roxana Mehran1, Gennaro Giustino2, Usman Baber2.   

Abstract

Entities:  

Keywords:  bleeding; major adverse cardiac event(s); stent thrombosis

Mesh：

Substances：

Year:  2015        PMID： 25790881     DOI： 10.1016/j.jacc.2015.01.024

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN： 0735-1097            Impact factor:   24.094


× No keyword cloud information.
  4 in total

Review 1.  Continuation of Dual-Antiplatelet Therapy Following Percutaneous Revascularization with a Drug-Eluting Stent: What Duration Is Optimal?

Authors:  Rupa K Patil; Rajesh V Swaminathan; Dmitriy N Feldman
Journal:  Curr Atheroscler Rep       Date:  2015-11       Impact factor: 5.113

2.  Long-term Safety and Efficacy of New-Generation Drug-Eluting Stents in Women With Acute Myocardial Infarction: From the Women in Innovation and Drug-Eluting Stents (WIN-DES) Collaboration.

Authors:  Gennaro Giustino; Rafael Harari; Usman Baber; Samantha Sartori; Gregg W Stone; Martin B Leon; Stephan Windecker; Patrick W Serruys; Adnan Kastrati; Clemens Von Birgelen; Takeshi Kimura; Giulio G Stefanini; George D Dangas; William Wijns; P Gabriel Steg; Marie-Claude Morice; Edoardo Camenzind; Giora Weisz; Pieter C Smits; Sabato Sorrentino; Madhav Sharma; Serdar Farhan; Michela Faggioni; David Kandzari; Soren Galatius; Raban V Jeger; Marco Valgimigli; Dipti Itchhaporia; Laxmi Mehta; Hyo-Soo Kim; Alaide Chieffo; Roxana Mehran
Journal:  JAMA Cardiol       Date:  2017-08-01       Impact factor: 14.676

3.  Antiplatelet Efficacy of Fixed-Dose Aspirin-Clopidogrel Combination in Patients with Stable Coronary Artery Disease Treated with Drug-Eluting Stent Implantation.

Authors:  Sungmin Lim; Pum Joon Kim; Chunyeong Baek; Tae-Hoon Kim; Yoon Seok Koh; Hun-Jun Park; Hee-Yeol Kim; Kiyuk Chang; Wook Sung Chung; Ki-Bae Seung
Journal:  Clin Drug Investig       Date:  2015-12       Impact factor: 2.859

4.  Thrombotic vs. Bleeding Events of Interruption of Dual Antiplatelet Therapy within 12 Months among Patients with Stent-Driven High Ischemic Risk Definition following PCI.

Authors:  Hao-Yu Wang; Bo Xu; Chen-Xi Song; Chang-Dong Guan; Li-Hua Xie; Yan-Yan Zhao; Zhong-Xing Cai; Sheng Yuan; Ke-Fei Dou
Journal:  J Interv Cardiol       Date:  2022-01-13       Impact factor: 2.279
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.